Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2009
12/03/2009US20090298751 Arylalkyl and Heteroarylalkyl Derivaties of Cyclosporine a for the Treatment and Prevention of Viral Infection
12/03/2009US20090298707 Sparse matrix system and method for identification of specific ligands or targets
12/03/2009US20090297689 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides
12/03/2009US20090297545 Immunomodulatory dairy peptides and uses thereof
12/03/2009US20090297527 Binding Domains of Proteins of the Repulsive Guidance Molecule (RGM) Protein Family and Functional Fragments Thereof, and Their Use
12/03/2009US20090297444 Peptide analogs of alpha-melanocyte stimulating hormone
12/02/2009EP2125878A1 Short bio-active peptides for cellular and immunological modulation
12/02/2009EP2125873A1 Novel therapeutics based on tau/microtubule dynamics
12/02/2009EP2125872A1 Basic peptides and their use as combined antibacterial-antifungine agents
12/02/2009EP2125862A1 Methods for the synthesis of cyclic peptides
12/02/2009EP2124910A2 Targeting of ews-fli1 as anti-tumor therapy
12/02/2009CN101591378A Worm body membrane bound short peptide ZL-4 with specific target and anti-schistosome function and application thereof
12/02/2009CN101591376A Oligopeptide with thrombolysis activity, preparation method and application thereof
12/01/2009US7625869 modified metastin containing aza-glycine, methyl arginine and N-acetyl tyrosine amino acids; cancer metastasis suppressing activity, a cancer growth suppressing activity
11/2009
11/26/2009WO2009142761A1 Caspofungin bo free of caspofungin co
11/26/2009WO2009142307A1 Peptide capable of extending half-life of peptide of interest in plasma
11/26/2009WO2009142086A1 Vaccine composition for mycoplasma infection
11/26/2009WO2009141240A1 Novel dual targeting antitumoural conjugates
11/26/2009WO2009140765A1 Selective caspase inhibitors and uses thereof
11/26/2009WO2009108716A3 Synthetic peptides
11/26/2009WO2009107971A3 Polypeptide specifically coupled to phosphatidylserine and use thereof
11/26/2009WO2009104974A3 Biomarkers for acute coronary disorder
11/26/2009US20090292108 Insulinotropic peptide synthesis using solid and solution phase combination techniques
11/26/2009US20090291902 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/26/2009US20090291899 Selective Modulation of Receptor Signalling
11/26/2009US20090291898 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
11/26/2009US20090291896 Genes encoding novel proteins with pesticidal activity against coleopterans
11/26/2009US20090291441 Polypeptide, nucleic acid molecule encoding it and their uses
11/26/2009US20090291104 Novel conotoxin framework with a helix-loop-helix fold
11/26/2009US20090291048 Leukocyte-binding polypeptides and uses thereof
11/26/2009CA2724785A1 Selective caspase inhibitors and uses thereof
11/26/2009CA2724562A1 Novel dual targeting antitumoural conjugates
11/26/2009CA2698582A1 Peptide having an extending action for half-life of object peptide in plasma
11/25/2009EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
11/25/2009EP2123667A1 Brain-migrating polypeptide having polyvalent bond and improved metabolic stability
11/25/2009EP2123666A1 Peptide
11/25/2009EP2121922A2 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered
11/25/2009EP2121730A2 Peptides, compositions and uses thereof
11/25/2009EP2120982A1 Polypeptides having modulatory effects on cells
11/25/2009EP2120974A1 Self-assembling amphiphilic polymers as antiviral agents
11/25/2009EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009CN101585867A Method for separating and purifying microcystin
11/25/2009CN101585866A Polypeptide for regulating activity of FGFR3 and screening method and application thereof
11/25/2009CN101585865A Ifbm's to promote attachment of target analytes
11/24/2009US7622556 Modified cytokines for use in cancer therapy
11/24/2009US7622551 Leukocyte stimulating peptides
11/24/2009US7622550 Mussel bioadhesive
11/24/2009US7622446 Polypeptides, derivatives and uses thereof
11/24/2009US7622263 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor
11/24/2009US7622261 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same
11/24/2009US7622127 Clostridial toxin derivatives and methods for treating pain
11/24/2009US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents
11/24/2009CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009WO2009139635A1 Polymyxin derivatives and uses thereof
11/19/2009WO2009139570A1 Peptides for targeting apoptotic cells and uses thereof
11/19/2009WO2009139497A1 Cbp501 -derived agents and methods based thereon for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
11/19/2009WO2009139298A1 Metastin derivative and use thereof
11/19/2009WO2009117480A8 Histidine related compounds for identifying and blocking amyloid beta ion channels
11/19/2009US20090286747 Mntf peptide compositions and methods of use
11/19/2009US20090286745 Inhibition of alpha-synuclein aggregation
11/19/2009US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009US20090286739 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090286722 Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell Function
11/19/2009US20090286719 Modification of cupredoxin derived peptides and methods of use thereof
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286314 Fluorescent proteins and genes encoding them
11/19/2009US20090286293 Ethanol production in non-recombinant hosts
11/19/2009US20090286224 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285820 Methods of Treating Degenerative Disorders With Rac 1B Inhibitor
11/19/2009US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009CA2722996A1 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue
11/18/2009EP2119725A1 Methods for the production of leuprolide
11/18/2009EP2119724A1 Solid-phase process foor the preparation of goserelin
11/18/2009EP2118272A2 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts
11/18/2009EP2118123A1 Stabilized p53 peptides and uses thereof
11/18/2009EP2117577A1 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders
11/18/2009EP2117576A1 Methods and compositions related to inhibition of viral entry
11/18/2009EP2117575A2 Methods and compositions related to clot binding compounds
11/18/2009EP2117571A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
11/18/2009EP1207873B1 Methods of inhibiting osteoclast activity
11/18/2009CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009CN101580537A Human cytomegalovirus UL 49 gene antigenic peptide, antibody thereof and use thereof
11/18/2009CN101580536A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/18/2009CN100560601C Derivative of cyclosporins C and D and pharmaceutical composition thereof
11/18/2009CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009USRE40987 for the treatment and prevention of AIDS
11/17/2009US7619059 Detectable, monitoring translation activation
11/17/2009US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/17/2009US7618637 Therapeutic mixture comprising chaperone protein for use in treatment and prevention of autoimmune, infectious and allergic disorders
11/17/2009CA2230949C Synthetic peptides that inhibit il-6 activity
11/12/2009WO2009137256A1 Biologically active peptides
11/12/2009WO2009136499A1 Aβ-OLIGOMER MEASUREMENT METHOD
11/12/2009WO2009136007A1 Peptide homing to brain tumors
11/12/2009WO2009112708A3 Novel peptide and cosmetic and/or pharmaceutical composition containing same
11/12/2009US20090281278 Modified molecules which promote hematopoiesis